For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Speaker Details

Joseph Schwartz MD, MPH, QIA(ASCP)CM, CABP(AABB)CM Senior Member, Department of Pathology/Hematopathology and Laboratory Medicine Moffitt Cancer Center and Research Institute USA


Dr. Schwartz received his MD from the Technion – Israel Institute of Technology and his MPH from Columbia University Mailman School of Public Health. He completed Internal Medicine residency & Hematology Fellowship in Israel and a Transfusion Medicine/Blood Banking Fellowship at New York Blood Center. Upon completion of training, he pursued a decades-long career in promoting excellence in the field of Transfusion Medicine, Apheresis & Cellular Therapy across a multitude of facilities. He had served as a Professor of Pathology & Cell Biology at Columbia University Irving Medical Center, and then a Professor of Pathology, Molecular, and Cell-based Medicine at the Icahn School of Medicine at Mount Sinai before moving to the Moffitt Cancer Center & Research Institute as a Senior Member Member in the Department of Pathology/Hematopathology and Laboratory Medicine. In these capacities, He amounted many years of experience directing Transfusion Medicine, Apheresis & Cellular Therapy Services.


Throughout his tenure in the field, Dr. Schwartz became an active member of the professional and academic community, serving on standardization committees, executive boards, and conference planning steering groups. He had been involved in many professional organizations including AABB, CAP, ISCT, and WBMT to name few. He served as a director and an officer of the American Society for Apheresis (ASFA), rising to be the president in 2018-2019. Seeking to impact clinical practice worldwide, he served on the writing committee of ASFA’s special issue (published on 3-year cycles) for the last five editions. Thus, he was part of the codification efforts of evidence-based best-in-class clinical Therapeutic Apheresis. Furthermore, he promoted quality and standardization through dissemination of the FACT-JACIE international standards for cellular therapy (Standards Committee Chair, Inspector, Workshop Speaker). For these efforts and many more, he Have had earned many honors including the AABB Hemphill Jordan Leadership Award (2019) , ASFA’s Presidential Award (2021) and ASFA’s Francis Morrison lectureship Award (2023).